|
06 Nov 2019 |
Ark Biosciences Reports Successful Completion of Phase II Proof-of-Concept Clinical Trial of Ziresovir for Treatment of Infants Hospitalized with Respiratory Syncytial Virus (RSV) Infection
|
|
06 Nov 2019 |
Takeda and MD Anderson Announce Collaboration to Accelerate the Development of Clinical-Stage, Off-The-Shelf CAR NK-Cell Therapy Platform
|
|
06 Nov 2019 |
Allogene Therapeutics and Notch Therapeutics Announce Collaboration to Research and Develop Induced Pluripotent Stem Cell (iPSC)-Derived Allogeneic Therapies for Hematologic Cancer Indications
|
|
05 Nov 2019 |
Aeromics and Simcere Announce Collaboration and License Agreement for AER-271 in Greater China
|
|
05 Nov 2019 |
BioCryst Announces Partnership With Torii Pharmaceutical to Commercialize BCX7353 in Japan for the Prevention of HAE Attacks
|
|
01 Nov 2019 |
Amgen Enters Into Strategic Collaboration With BeiGene To Expand Oncology Presence In China
|
|
01 Nov 2019 |
Dicerna Enters Agreement with Roche to Develop and Commercialize DCR-HBVS for the Treatment of Chronic Hepatitis B Virus (HBV) Infection
|
|
31 Oct 2019 |
Pandion and Astellas Announce Collaboration to Deliver Pancreas-Targeted Immunomodulators
|
|
30 Oct 2019 |
LEO Pharma enters into option agreement with Ubiquigent for access to novel compounds
|
|
29 Oct 2019 |
Pascal Biosciences and Y-Biologics Announce Research Collaboration for Development of a Bispecific Antibody for Leukemia
|
|
28 Oct 2019 |
Ziopharm Oncology and MD Anderson Cancer Center Announce New R&D Agreement to Expand TCR-T Program
|
|
28 Oct 2019 |
Molecular Targeting Technologies, Inc. Receives Global Rights From NIH for Integrin-Targeting Radiotherapeutics to Treat GBM and Lung Cancer
|
|
26 Oct 2019 |
AbbVie Announces Collaboration with Cystic Fibrosis Foundation
|
|
23 Oct 2019 |
Pliant Therapeutics Announces Strategic Collaboration to Develop Novel Therapies for NASH and Fibrotic Diseases
|
|
23 Oct 2019 |
Ambrx and NovoCodex form Second Collaboration to Develop and Commercialize Ambrx's Antibody Drug Conjugates
|
|
22 Oct 2019 |
Zealand Pharma expands its peptide platform with acquisition of Encycle Therapeutics
|
|
22 Oct 2019 |
Takeda Acquires License for First-In-Class Celiac Disease Therapy from COUR Pharmaceuticals Following Positive Phase 2a Proof-of-Concept Study
|
|
21 Oct 2019 |
Bavarian Nordic Announces a Transformative Acquisition of Two Established Commercial Vaccines from GlaxoSmithKline
|
|
21 Oct 2019 |
pH Pharma and Immunome Enter into Collaboration and License Agreement to Develop and Commercialize Multiple Novel Antibody-Drug Conjugates in Oncology
|
|
21 Oct 2019 |
CRISPR Therapeutics and Bayer Announce an Update on Casebia Therapeutics
|
|
16 Oct 2019 |
Alexion to Acquire Achillion
|
|
16 Oct 2019 |
Editas Medicine and AskBio Enter Strategic Research Collaboration to Explore In Vivo Delivery of Genome Editing Medicines to Treat Neurological Diseases
|
|
16 Oct 2019 |
Ipsen and Blueprint Medicines Announce Exclusive Global License Agreement to Develop and Commercialize BLU-782 for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)
|
|
15 Oct 2019 |
CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companies’ Respective Cell Therapy Programs in Oncology
|
|
11 Oct 2019 |
Shionogi enters into a new license agreement and research collaboration for the treatment of mycobacterial diseases with Hsiri Therapeutics, Inc.
|
